Chimera Investment (NYSE:CIM – Get Free Report) is anticipated to issue its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect the company to post earnings of $0.5380 per share and revenue of $95.3020 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:30 AM ET.
Chimera Investment (NYSE:CIM – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The real estate investment trust reported $0.54 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.02. Chimera Investment had a net margin of 2.27% and a return on equity of 9.36%. The firm had revenue of $32.37 million during the quarter, compared to analysts’ expectations of $102.35 million.
Chimera Investment Trading Down 0.1%
NYSE:CIM opened at $12.46 on Monday. The business’s 50-day moving average is $13.14 and its two-hundred day moving average is $13.18. The company has a debt-to-equity ratio of 2.31, a current ratio of 0.08 and a quick ratio of 0.08. Chimera Investment has a 12 month low of $11.67 and a 12 month high of $14.88. The firm has a market capitalization of $1.04 billion, a PE ratio of -15.58 and a beta of 1.67.
Chimera Investment Dividend Announcement
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on CIM shares. Royal Bank Of Canada reiterated a “sector perform” rating and set a $14.00 target price on shares of Chimera Investment in a report on Wednesday, June 3rd. Weiss Ratings cut Chimera Investment from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, May 20th. Finally, Wall Street Zen raised shares of Chimera Investment from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Chimera Investment presently has a consensus rating of “Hold” and an average price target of $14.75.
Read Our Latest Analysis on CIM
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the business. Mercer Global Advisors Inc. ADV acquired a new stake in Chimera Investment during the 3rd quarter valued at approximately $242,000. Vident Advisory LLC raised its position in shares of Chimera Investment by 33.8% in the 2nd quarter. Vident Advisory LLC now owns 17,123 shares of the real estate investment trust’s stock valued at $237,000 after purchasing an additional 4,322 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Chimera Investment during the 2nd quarter valued at approximately $235,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Chimera Investment by 29.4% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 17,313 shares of the real estate investment trust’s stock valued at $229,000 after buying an additional 3,937 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new stake in shares of Chimera Investment during the fourth quarter worth approximately $223,000. Institutional investors and hedge funds own 48.44% of the company’s stock.
About Chimera Investment
Chimera Investment Corporation (NYSE: CIM) is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company’s portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.
The firm’s core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.
Read More
- Five stocks we like better than Chimera Investment
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.
